Multiple Myeloma Management 17+

Med Learning Group

Designed for iPad

    • Free

Screenshots

Description

This program discusses relapsed/refractory multiple myeloma and role of BCMA therapies

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.

App Privacy

The developer, Med Learning Group, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Not Collected

The developer does not collect any data from this app.

Privacy practices may vary based on, for example, the features you use or your age. Learn More

More By This Developer

CV Augmented Reality
Education
Covid Frontline AR
Medical
AMD & Anti-VEGF Therapy
Medical
Squamous Cell Cancer-Head/Neck
Education
Antiarrhythmics for Afib
Education
Non-Small-Cell Lung Cancer
Medical

You Might Also Like

Multiple Myeloma [MM]
Medical
Multiple Myeloma Manager
Medical
SurvivorNet
Health & Fitness
HealthTree
Health & Fitness
Boss Chick TV: Twerk Fitness
Health & Fitness
eKare inSight CR
Medical